Literature DB >> 16822839

Akt down-regulates ERK1/2 nuclear localization and angiotensin II-induced cell proliferation through PEA-15.

Marianne Gervais1, Céline Dugourd, Laurent Muller, Corinne Ardidie, Brigitte Canton, Laetitia Loviconi, Pierre Corvol, Hervé Chneiweiss, Catherine Monnot.   

Abstract

Angiotensin II (AngII) type 1 receptors (AT1) regulate cell growth through the extracellular signal-regulated kinase (ERK)1/2 and phosphatidylinositol 3-kinase (PI3K) pathways. ERK1/2 and Akt/protein kinase B, downstream of PI3K, are independently activated but both required for mediating AngII-induced proliferation when expressed at endogenous levels. We investigate the effect of an increase in the expression of wild-type Akt1 by using Chinese hamster ovary (CHO)-AT1 cells. Unexpectedly, Akt overexpression inhibits the AT1-mediated proliferation. This effect could be generated by a cross-talk between the PI3K and ERK1/2 pathways. A functional partner is the phosphoprotein enriched in astrocytes of 15 kDa (PEA-15), an Akt substrate known to bind ERK1/2 and to regulate their nuclear translocation. We report that Akt binds to PEA-15 and that Akt activation leads to PEA-15 stabilization, independently of PEA-15 interaction with ERK1/2. Akt cross-talk with PEA-15 does not affect ERK1/2 activation but decreases their nuclear activity as a result of the blockade of ERK1/2 nuclear accumulation. In response to AngII, PEA-15 overexpression displays the same functional consequences on ERK1/2 signaling as Akt overactivation. Thus, Akt overactivation prevents the nuclear translocation of ERK1/2 and the AngII-induced proliferation through interaction with and stabilization of endogenous PEA-15.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16822839      PMCID: PMC1593169          DOI: 10.1091/mbc.e06-06-0501

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  39 in total

1.  The death effector domain of PEA-15 is involved in its regulation of integrin activation.

Authors:  J W Ramos; T K Kojima; P E Hughes; C A Fenczik; M H Ginsberg
Journal:  J Biol Chem       Date:  1998-12-18       Impact factor: 5.157

2.  The major astrocytic phosphoprotein PEA-15 is encoded by two mRNAs conserved on their full length in mouse and human.

Authors:  A Estellés; M Yokoyama; F Nothias; J D Vincent; J Glowinski; P Vernier; H Chneiweiss
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

3.  Cellular expression, developmental regulation, and phylogenic conservation of PEA-15, the astrocytic major phosphoprotein and protein kinase C substrate.

Authors:  N Danziger; M Yokoyama; T Jay; J Cordier; J Glowinski; H Chneiweiss
Journal:  J Neurochem       Date:  1995-03       Impact factor: 5.372

4.  PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis.

Authors:  G Condorelli; G Vigliotta; A Cafieri; A Trencia; P Andalò; F Oriente; C Miele; M Caruso; P Formisano; F Beguinot
Journal:  Oncogene       Date:  1999-08-05       Impact factor: 9.867

5.  PI-3-kinase and MAPK regulate mesangial cell proliferation and migration in response to PDGF.

Authors:  G G Choudhury; C Karamitsos; J Hernandez; A Gentilini; J Bardgette; H E Abboud
Journal:  Am J Physiol       Date:  1997-12

6.  Cell cycle progression and activation of Akt kinase are required for insulin-like growth factor I-mediated suppression of apoptosis in granulosa cells.

Authors:  Che-Lin Hu; Robert G Cowan; Rebecca M Harman; Susan M Quirk
Journal:  Mol Endocrinol       Date:  2003-10-30

7.  Human NCI-H295 adrenocortical carcinoma cells: a model for angiotensin-II-responsive aldosterone secretion.

Authors:  I M Bird; N A Hanley; R A Word; J M Mathis; J L McCarthy; J I Mason; W E Rainey
Journal:  Endocrinology       Date:  1993-10       Impact factor: 4.736

8.  PEA-15 binding to ERK1/2 MAPKs is required for its modulation of integrin activation.

Authors:  Fan-Li Chou; Justine M Hill; Jyh-Cheng Hsieh; Jacques Pouyssegur; Anne Brunet; Angela Glading; Florian Uberall; Joe W Ramos; Milton H Werner; Mark H Ginsberg
Journal:  J Biol Chem       Date:  2003-09-23       Impact factor: 5.157

9.  Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry.

Authors:  A Brunet; D Roux; P Lenormand; S Dowd; S Keyse; J Pouysségur
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

10.  A recombinant rat vascular AT1 receptor confers growth properties to angiotensin II in Chinese hamster ovary cells.

Authors:  B Teutsch; C Bihoreaú; C Monnot; K E Bernstein; T J Murphy; R W Alexander; P Corvol; E Clauser
Journal:  Biochem Biophys Res Commun       Date:  1992-09-30       Impact factor: 3.575

View more
  18 in total

1.  The death effector domain protein PEA-15 negatively regulates T-cell receptor signaling.

Authors:  Sandra Pastorino; Hemamalini Renganathan; Maisel J Caliva; Erin L Filbert; John Opoku-Ansah; Florian J Sulzmaier; Joanna E Gawecka; Guy Werlen; Andrey S Shaw; Joe W Ramos
Journal:  FASEB J       Date:  2010-03-30       Impact factor: 5.191

2.  Overexpression of MUC1 enhances proangiogenic activity of non-small-cell lung cancer cells through activation of Akt and extracellular signal-regulated kinase pathways.

Authors:  Mengying Yao; Weihong Zhang; Qingxian Zhang; Lihua Xing; Aiguo Xu; Qiuhong Liu; Bing Cui
Journal:  Lung       Date:  2011-10-01       Impact factor: 2.584

Review 3.  Nuclear and mitochondrial signalling Akts in cardiomyocytes.

Authors:  Shigeki Miyamoto; Marta Rubio; Mark A Sussman
Journal:  Cardiovasc Res       Date:  2009-03-11       Impact factor: 10.787

4.  ERK nuclear translocation is dimerization-independent but controlled by the rate of phosphorylation.

Authors:  Diane S Lidke; Fang Huang; Janine N Post; Bernd Rieger; Julie Wilsbacher; James L Thomas; Jacques Pouysségur; Thomas M Jovin; Philippe Lenormand
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

5.  Naringenin attenuates mucous hypersecretion by modulating reactive oxygen species production and inhibiting NF-κB activity via EGFR-PI3K-Akt/ERK MAPKinase signaling in human airway epithelial cells.

Authors:  J Yang; Q Li; X D Zhou; V P Kolosov; J M Perelman
Journal:  Mol Cell Biochem       Date:  2011-01-13       Impact factor: 3.396

6.  Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells.

Authors:  Borhane Annabi; Eric Vaillancourt-Jean; Alexander G Weil; Richard Béliveau
Journal:  Onco Targets Ther       Date:  2010-11-15       Impact factor: 4.147

Review 7.  How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?

Authors:  Yohannes Mebratu; Yohannes Tesfaigzi
Journal:  Cell Cycle       Date:  2009-04-11       Impact factor: 4.534

8.  Na/H exchange regulatory factor 1, a novel AKT-associating protein, regulates extracellular signal-regulated kinase signaling through a B-Raf-mediated pathway.

Authors:  Bin Wang; Yanmei Yang; Peter A Friedman
Journal:  Mol Biol Cell       Date:  2008-02-13       Impact factor: 4.138

9.  Krüppel-like factor 4 inhibits proliferation by platelet-derived growth factor receptor beta-mediated, not by retinoic acid receptor alpha-mediated, phosphatidylinositol 3-kinase and ERK signaling in vascular smooth muscle cells.

Authors:  Bin Zheng; Mei Han; Michel Bernier; Xin-hua Zhang; Fang Meng; Sui-bing Miao; Ming He; Xin-ming Zhao; Jin-kun Wen
Journal:  J Biol Chem       Date:  2009-06-16       Impact factor: 5.157

10.  The trafficking protein GABARAP binds to and enhances plasma membrane expression and function of the angiotensin II type 1 receptor.

Authors:  Julia L Cook; Richard N Re; Dawn L deHaro; Jennifer M Abadie; Michelle Peters; Jawed Alam
Journal:  Circ Res       Date:  2008-05-22       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.